Skip to content

Feasibility Study for Treating Trichotillomania With Wearable Device and App System

Feasibility Study for Treating Trichotillomania With Wearable Device and App System Using Habit Reversal Training

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04241120
Enrollment
15
Registered
2020-01-27
Start date
2020-01-16
Completion date
2020-03-04
Last updated
2023-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trichotillomania

Keywords

Hair Pulling Disorder, Body-Focused Repetitive Behaviors, Trichotillomania

Brief summary

Trichotillomania is characterized by recurrent hair pulling resulting in hair loss causing significant distress and impairment which persists despite repeated attempts to stop. Behavioral based therapies focused on increasing awareness of hair pulling followed by the use of an incompatible behavior have proven effective. In an effort to enhance awareness, a wrist worn motion detection device was created. In this study, we will test the feasibility of the HabitAware device and accompanying app as a system for delivering self-administered habit reversal training (HRT).

Interventions

BEHAVIORALDevice and app system designed for participant to self-administer Habit Reversal Training

Participants will receive an awareness bracelet and an app that work together to implement key features of Habit Reversal Training. The participant will take part in psychoeducation, awareness training, and competing response training related to trichotillomania.

BEHAVIORALReminder bracelet control condition

Participants will receive a bracelet programmed to vibrate randomly several times per hour during waking hours. They will be instructed this is a reminder not to pull.

Sponsors

Marquette University
CollaboratorOTHER
National Institute of Mental Health (NIMH)
CollaboratorNIH
HabitAware Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. 18 years of age or older 2. Speak fluent English 3. Current diagnosis of TTM 4. Score above the normative mean on the automatic pulling subscale of the MIST-A 5. Not on psychotropic medication or on a stable dose (i.e., same dose for past 6 weeks)

Exclusion criteria

1. Currently receiving psychotherapy 2. Other psychiatric condition requiring more immediate care 3. Have previously used any behavior awareness devices (e.g. Keen)

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Participants in the HabitAware Condition That Wore the Device for 6 Hours Per Day and More Than 4 Days Per Week.Four weeksMeasured via post-treatment surveys.

Secondary

MeasureTime frameDescription
Percentage of Participants That Reported the Device >3 on a Scale of 1-5 for Accuracy.Four weeksMeasured by post treatment survey results
Number of Participants That Can Implement HRT Procedures With 80% AccuracyFour weeksMeasured by trained clinician observing the participant perform the procedures
Number of Participants With 30% Improvement in Clinical SymptomsFour weeksMeasured via pre- and post-treatment MGH-HPS (Massachusetts General Hospital Hair Pulling Scale) and/or NIMH-TSS (National Institute of Mental Health - Trichotillomania Symptom Severity) scores for those in the HabitAware conditions.

Countries

United States

Participant flow

Participants by arm

ArmCount
Experimental Group - HabitAware Condition
This group will receive the device which alerts the participant when performing hair pulling behavior and the app which provides psychoeducation and components of Habit Reversal Training. Device and app system designed for participant to self-administer Habit Reversal Training: Participants will receive an awareness bracelet and an app that work together to implement key features of Habit Reversal Training. The participant will take part in psychoeducation, awareness training, and competing response training related to trichotillomania.
10
Control Group - Reminder Bracelet Condition
This group will receive only a device that vibrates randomly several times per hour as a reminder not to pull. Reminder bracelet control condition: Participants will receive a bracelet programmed to vibrate randomly several times per hour during waking hours. They will be instructed this is a reminder not to pull.
5
Total15

Baseline characteristics

CharacteristicControl Group - Reminder Bracelet ConditionTotalExperimental Group - HabitAware Condition
Age, Continuous31.2 years
STANDARD_DEVIATION 7.6
36.7 years
STANDARD_DEVIATION 13.7
39.5 years
STANDARD_DEVIATION 15.5
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants2 Participants2 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
5 Participants13 Participants8 Participants
Sex: Female, Male
Female
5 Participants15 Participants10 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 100 / 5
other
Total, other adverse events
0 / 100 / 5
serious
Total, serious adverse events
0 / 100 / 5

Outcome results

Primary

Percentage of Participants in the HabitAware Condition That Wore the Device for 6 Hours Per Day and More Than 4 Days Per Week.

Measured via post-treatment surveys.

Time frame: Four weeks

Population: This outcome measure was only for the experimental group.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Experimental Group - HabitAware ConditionPercentage of Participants in the HabitAware Condition That Wore the Device for 6 Hours Per Day and More Than 4 Days Per Week.9 Participants
Control Group - Reminder Bracelet ConditionPercentage of Participants in the HabitAware Condition That Wore the Device for 6 Hours Per Day and More Than 4 Days Per Week.0 Participants
Secondary

Number of Participants That Can Implement HRT Procedures With 80% Accuracy

Measured by trained clinician observing the participant perform the procedures

Time frame: Four weeks

Population: This outcome measure was only for the experimental group.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Experimental Group - HabitAware ConditionNumber of Participants That Can Implement HRT Procedures With 80% Accuracy4 Participants
Control Group - Reminder Bracelet ConditionNumber of Participants That Can Implement HRT Procedures With 80% Accuracy0 Participants
Secondary

Number of Participants With 30% Improvement in Clinical Symptoms

Measured via pre- and post-treatment MGH-HPS (Massachusetts General Hospital Hair Pulling Scale) and/or NIMH-TSS (National Institute of Mental Health - Trichotillomania Symptom Severity) scores for those in the HabitAware conditions.

Time frame: Four weeks

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Experimental Group - HabitAware ConditionNumber of Participants With 30% Improvement in Clinical Symptoms6 Participants
Control Group - Reminder Bracelet ConditionNumber of Participants With 30% Improvement in Clinical Symptoms3 Participants
Secondary

Percentage of Participants That Reported the Device >3 on a Scale of 1-5 for Accuracy.

Measured by post treatment survey results

Time frame: Four weeks

Population: This outcome measure was only for the experimental group.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Experimental Group - HabitAware ConditionPercentage of Participants That Reported the Device >3 on a Scale of 1-5 for Accuracy.10 Participants
Control Group - Reminder Bracelet ConditionPercentage of Participants That Reported the Device >3 on a Scale of 1-5 for Accuracy.0 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026